le Roux CW, Wharton S, Bozkurt B, Platz E, et al. Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE-1). Diabetes Obes Metab 2026;28:337-346.
PMID: 41187967